PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mansfield AS et al. – The patient's medications included stable doses of aspirin, atenolol, atorvastatin, calcium acetate, insulin, gabapentin, and more recently vancomycin. He had been taking 300 mg of gabapentin 4 times daily for several years, which effectively controlled his diabetic neuropathic pain. Vancomycin was administered during hemodialysis according to blood levels. He had been adherent to his medication and dialysis regimen.

Related Articles

Injury time - losing out in acute kidney injury
British Journal of Renal Medicine, 10/26/09    Relevance Score: 68%

The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09    Relevance Score: 68%

Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets, 11/03/09    Relevance Score: 67%

A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09    Relevance Score: 67%

Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure
BMC Nephrology, 10/27/09    Relevance Score: 67%

Today in Nephrology...keeping you current

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/25/09

Tracing the Origin of Glomerular Extracapillary Lesions from Parietal Epithelial Cells
Journal of the American Society of Nephrology, 11/25/09

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Journal of the American Society of Nephrology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address